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Abstract
Background: in older persons, anaemia is associated with a number of unfavourable outcomes. In approximately 30% of
older persons with anaemia, the cause of the anaemia is unexplained. We assessed the clinical differences between subjects
with explained and unexplained anaemia and investigated whether these subjects have different mortality patterns compared
with subjects without anaemia.
Design: observational prospective follow-up study.
Setting: the Leiden 85-plus study.
Participants: four hundred and ninety-one persons aged 86 years.
Methods: the study population was divided in three groups: (i) no anaemia (reference group, n= 377), (ii) explained
anaemia (iron deficiency, folate deficiency, vitamin B12 deficiency, signs of myelodysplastic syndrome or renal failure,
n= 74) and (iii) unexplained anaemia, (n = 40). Mortality risks were estimated with Cox-proportional hazard models.
Results: haemoglobin levels were significantly lower in subjects with explained anaemia than in subjects with unexplained
anaemia (P < 0.01). An increased risk for mortality was observed in subjects with explained anaemia [HR: 1.93 (95% CI:
1.47–2.52), P < 0.001], but not in subjects with unexplained anaemia [HR: 1.19 (95% CI: 0.85–1.69), P = 0.31]. Adjusted
analyses (sex, co-morbidity, MMSE, institutionalised and smoking) did not change the observed associations for both
explained and unexplained anaemic subjects.
Conclusion: older subjects with unexplained anaemia had similar survival compared with non-anaemic subjects. Increased
mortality risks were observed in subjects with explained anaemia compared with non-anaemic subjects.
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The incidence and prevalence of anaemia increase with age
[1, 2]. In older subjects anaemia is associated with unfavour-
able events including death [3–6], dementia [7], cardiovascu-
lar diseases [8] and functional dependence [9, 10]. Clinical
investigation into the cause of anaemia in older patients is
often complicated by the co-morbidity characterising this
patient group. Especially cognitive disorders and physical
disabilities hamper reliable history taking and physical
examinations, the cornerstones of medical practice.
Therefore in clinical practice, the initial laboratory results
are indicative for making the decision for further and often
more invasive investigations in these patients. Since any
procedure may lead to a deterioration of the current condi-
tion of the older patient invasive investigations should be
limited to a minimum.
Chronic renal failure and iron deficiency are the most
common causes for anaemia in older subjects [1, 11, 12],
often caused by severe underlying diseases such as athero-
sclerosis and gastro-intestinal malignancies, respectively.
Other well known causes in clinical practice for anaemia
are folate and vitamin B12 deficiency. The role of vitamin
B12 deficiency as predictor for the presence of anaemia in
this population, however, is still subject to discussion [13,
14]. Another serious cause of anaemia in the elderly is mye-
lodysplastic syndrome (MDS), a heterogeneous disorder
characterised by ineffective haematopoiesis resulting in low
peripheral blood counts [15, 16].
Several epidemiological studies have found that up to
30% of anaemia in the older population is unexplained,
even when extensive clinical information is available [15, 17,
18]. The clinical relevance of unexplained anaemia is
unclear. In the present study, we assessed clinical differ-
ences between explained and unexplained anaemia in older




All data were derived from the Leiden 85-plus Study, a pro-
spective follow-up study of subjects aged 85 years at base-
line. At baseline, all individuals were living in Leiden, The
Netherlands. There were no exclusion criteria for study par-
ticipation. All subjects were visited at their place of resi-
dence where interviews took place and venous blood
samples were drawn. Between 1997 and 1999, the Leiden
85-plus Study enrolled 599 subjects at baseline [19]. For the
present analysis, we included 491 subjects aged 86 years.
Of the 108 subjects that were not included in the present
analysis, 47 died before the age of 86 years, 39 refused
further participation, 16 refused blood sampling and in 6
subjects no erythropoietin measurement was available due
to technical problems. The Medical Ethical Committee of
the Leiden University Medical Center (LUMC) approved
the study and all participants provided informed consent
for study participation.
Laboratory measurements
All blood samples were collected in sterile EDTA tubes.
Measurements of haemoglobin, mean corpuscular volume
and erythrocyte count, white blood cell count and platelet
count were done with a fully automated system (Sysmex
XE-2100, TOA Medical Electronics, Kobe, Japan). Serum
erythropoietin levels were measured using the enzyme im-
munoassay (EIA, Immulite 2500, Siemens Medical
Diagnostics, Tarrytown, NY, USA), which had a sensitivity
of 1.2 mU/ml and a coefficient of variation less than 6%.
Creatinine was measured according to the Jaffe method
(Hitachi 747, Tokyo, Japan). Creatinine clearance was esti-
mated with the Modification of Diet in Renal Disease equa-
tion (MDRD) [20]. C-reactive protein (CRP) measurement
was done in one batch using the Dual Count Solid Phase
No Boil Assay (Diagnostic Products Corp, Los Angeles,
CA, USA). Ferritin, folate and vitamin B12 were deter-
mined in one batch using the Dual Count Solid Phase No
Boil Assay (Diagnostic Products Corp, Los Angeles, CA,
USA).
Mortality
All subjects were followed up for mortality until 1 February
2008. For the deceased participants, the cause of death was
obtained from Statistics Netherlands. Only the primary
cause of death on the death certificate was used in our ana-
lyses. The international classification of diseases (ICD)
codes I00-I99 were used for cardiovascular mortality. For
non-vascular mortality, all ICD codes except I00-I99 were
used.
Study groups
For the present study, the study population was divided in
three groups: a group with no anaemia (reference group), a
group with a known cause for anaemia (explained anaemia)
and a group with an unknown cause for anaemia (unex-
plained anaemia). Explained and unexplained anaemia are
two different identities; explained anaemia, often due to
chronic diseases or malignancies, is characterised by signifi-
cant higher CRP, Interleukin-6 levels or higher erythropoi-
etin levels. In persons with unexplained anaemia, lower
CRP, lower lymphocyte counts and EPO levels are found,
assuming a totally different pathophysiological form of
anaemia. Anaemia was defined according to the criteria of
the World Health Organization [21] as haemoglobin levels
lower than 12.0 g/dl (7.5 mmol/l) for women and 13.0 g/
dl (8.1 mmol/l) for men. Explained anaemia was defined
as anaemia in the presence of iron deficiency (ferritin <20
ng/ml), renal failure (MDRD <50 ml/min/m2), vitamin
B12 deficiency (<150 pmol/ml), folate deficiency (<7.0
nmol/ml) or signs of MDS. MDS was defined as anaemia
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together with leucopenia (white blood cell count less than
3.5 × 109) or thrombopenia (platelet count less than 150 ×
109). Unexplained anaemia was defined as the presence of
anaemia with normal ferritin, vitamin B12, folate and cre-
atinine concentrations.
Additional study parameters
Information on the presence of chronic disease (diabetes
mellitus, chronic obstructive pulmonary disease (COPD),
arthritis, myocardial infarction, heart failure, stroke and ma-
lignancy) was obtained from general practitioners, nursing
home physicians and pharmacy records [22]. Cognitive
function was measured with the Mini-Mental State
Examination (MMSE) [23]. All participants were inter-
viewed about current and former smoking habits.
Statistical analyses
Data are presented as number (percentages) for dichotom-
ous parameters and as a median (inter-quartile range) for
continuous parameters. Differences in laboratory values
between anaemic (both explained and unexplained) and
non-anaemic subjects (the reference group) were deter-
mined by Mann–Whitney U test. Mortality differences
between anaemic and non-anaemic subjects were assessed
with Cox regression analysis, adjusted for gender,
co-morbidity, MMSE, institutionalisation, smoking and
haemoglobin level. Mortality was visually depicted with
Kaplan–Meier survival curves. Mortality differences between
subjects with explained and unexplained anaemia were add-
itionally adjusted for the haemoglobin level.
Since previous results from the Leiden 85-plus Study
showed no association between vitamin B12 deficiency and
anaemia [13], we repeated all analyses excluding vitamin
B12 deficiency from the explained anaemic group.
The SPSS software (version 16.0.1, SPSS, Inc, Chicago,
IL, USA) was used for all statistical analyses. P-values lower
than 0.05 were considered statistically significant.
Results
Baseline characteristics of the 491 subjects are presented in
Table 1. A total of 108 (22%) subjects were institutionalised
in a nursing home or care home for older persons, 315
(64%) had one or more chronic diseases, 49 (10%) had a
history of myocardial infarction and 58 (12%) a history of
stroke. A total of 131 subjects (27%) had renal insufficiency
with an estimated glomerular filtration rate <50 ml/min/
1.73 m2 (MDRD). Of the 114 (23%) cases of anaemia, 74
(65%) were explained and 40 (35%) were unexplained. Of
the 74 subjects with explained anaemia, 13 (19%) had iron
deficiency, 42 (56%) had renal failure, 4 (5%) folate defi-
ciency, 11 (15%) vitamin B12 deficiency and 4 (5%) MDS.
Table 2 shows the haematological characteristics of the
subjects with explained anaemia, unexplained anaemia and
their counterparts without anaemia. Haemoglobin levels
were significantly lower in the subjects with explained
anaemia than in the subjects with unexplained anaemia (P
< 0.01) As expected, median erythropoietin levels were sig-
nificantly higher in the subjects with anaemia than in the
subjects without anaemia (9.6 mIU/ml) (P < 0.01).
However, median erythropoietin levels were similar in sub-
jects with explained anaemia and those with unexplained
anaemia, (11.5 mIU/ml versus 12.1 mIU/ml, P = 0.88).
Only in the group with explained anaemia, CRP was signifi-
cantly higher than in those without anaemia (P < 0.05). No
differences in comorbid illnesses (malignancies, diabetes
mellitus, COPD, arthritis, myocardial infarction and stroke),
smoking, MMSE and institutionalisation were found
between the explained and unexplained anaemic groups
(data not shown).
Survival differences between subjects with explained
anaemia, unexplained anaemia and without anaemia from
age 86 onwards are visually depicted in Figure 1. An
increased risk for all-cause mortality was found in the
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Baseline characteristics of the subjects at age 86
n= 491
Women (%) 331 (67)
Institutionalised (%) 108 (22)
MMSE score (median, IQR) 26 (22–28)
Current and/or past smoking (%) 231 (47)
Chronic diseases (%) 315 (64)
Malignancies (%) 92 (19)
Diabetes mellitus (%) 73 (15)
COPD (%) 49 (10)
Arthritisa (%) 162 (33)
Renal insufficiencyb (%) 131 (27)
Myocardial infarction (%) 49 (10)
Stroke (%) 58 (12)
Anaemia (%) 114 (23)
Explained anaemia (%) 74 (15)
Iron deficiencyc (%) 13 (19)
Renal anaemiad (%) 42 (57)
Vitamin B12 deficiencye (%) 11 (15)
Folate deficiencyf (%) 4 (5)
Myelodysplastic syndromeg (%) 4 (5)
Unexplained anaemia (%) 40 (8)
Follow-up time (years) 6 (3–9)
MMSE, Mini Mental State Examination; COPD, chronic obstructive
pulmonary disease.
Continuous parameters are presented as median (inter-quartile range).
Categorial data are presented as numbers (percentages).
aArthritis was defined as polymyalgia rheumatica, rheumatoid arthritis and
osteoarthrosis.
bRenal insufficiency was defined as creatinine clearance <50 ml/min/1.73 m2
calculated by the Modification of Diet in Renal Disease formula.
cIron deficiency was defined as ferritin <20 ng/ml.
dRenal anaemia was defined as having anaemia and creatinine clearance <50
ml/min/1.73 m2.
eVitamin B12 deficiency was defined as <150 pmol/ml.
fFolate deficiency was defined as <7.0 nmol/ml.
gMyelodysplastic syndrome vitamin was defined as anaemia together with
leucopenia (white blood cell count less than 3.5 × 109), and thrombopenia
(platelet count less than 150 × 109).
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group of subjects with explained anaemia (HR: 1.93, 95%
CI: 1.47–2.52), P < 0.001) compared with the group of
subjects without anaemia. Subjects with unexplained
anaemia had no increased risk for all-cause mortality com-
pared with non-anaemic subjects (HR: 1.19 (95% CI: 0.85–
1.69), P = 0.31). Adjustment for sex, co-morbidity, MMSE,
institutionalisation and smoking did not change these asso-
ciations for subjects with explained anaemia [HR: 1.93
(95% CI: 1.23–3.02), P = 0.004] and for subjects with un-
explained anaemia [HR: 1.19 (95% CI: 0.79–1.79), P =
0.39]. When we repeated all analyses excluding vitamin B12
deficiency from the explained anaemic group, the results
were not materially different.
Subjects with explained anaemia had an increased mortal-
ity risk compared with subjects with unexplained anaemia
[HR: 1.61 (95% CI: 1.09–2.21), P= 0.04]. Adjustment for
sex, co-morbidity, MMSE, institutionalisation, smoking and
haemoglobin did not change this association. In this analysis,
sex [HR: 2.15 (95% CI: 1.59–2.90), P< 0.0001], haemo-
globin level [HR: 1.41 (95% CI: 1.16–1.73), P= 0.001], CRP
[HR: 1.02 (95% CI: 1.00–1.02), P= 0.001] and MMSE
[HR: 1.07 (95% CI: 1.04–1.09), P= 0.0001] were independ-
ently associated with mortality risk.
Furthermore, the all-cause, cardiovascular and non-
cardiovascular mortality risks for participants with
explained and unexplained anaemia were studied. No statis-
tically significant differences were found in cardiovascular
mortality risk between the explained and unexplained
anaemic group [HR: 1.83 (95% CI: 0.90–3.74), P = 0.09].
However, no difference was found in non-cardiovascular
mortality risk between these two groups [HR: 1.36 (95%
CI: 0.81–2.32), P= 0.24] (data not shown).
Discussion
The main finding of this study is that older subjects with
explained anaemia had an almost twofold increased mortal-
ity risk compared with subjects without anaemia, whereas
in subjects with unexplained anaemia no excess mortality
was found. These findings possibly suggest that in older
persons anaemia is only relevant for survival when a clinical
explanation for the cause of anaemia can be demonstrated.
In our study sample, we found that in 37% of anaemic
subjects no clinical explanation for anaemia could be found
similar to earlier reports. Data from a non-institutionalised
US population assessed in the third National Health and
Nutrition Examination Survey (1988–94) showed that un-
explained anaemia was present in one-third of the older
adults (>65 years) with anaemia [1]. Another study reported
that no evident cause for anaemia in a representative
sample of older Europeans (>65 years) was found in
Figure 1. Survival of subjects with no anaemia (n= 377),
explained anaemia (n= 74) and unexplained anaemia (n = 40)
from age 86.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Clinical characteristics of study participants by anaemia status
Explained anaemia (n= 74) Unexplained anaemia (n= 40) Without anaemia (n= 377)
Haemoglobin (g/dl) 11.4 (10.4–11.8)** 11.7 (11.2–12.2)** 13.4 (12.8–14.1)
Haematocrit (%) 0.35 (0.32–0.36)** 0.36 (0.34–0.37)** 0.41 (0.38–0.43)
MCV (fL) 90 (86–93)** 91 (88–94) 91 (89–94)
Erythrocytes (× 109/l) 3.9 (3.6–4.1)** 3.9 (3.7–4.1)** 4.5 (4.3–4.7)
Leucocytes (× 109/l) 6.5 (5.1–7.6) 6.0 (5.0–7.1) 6.3 (5.3–7.5)
Platelets (× 109/l) 225 (172–272) 235 (194–282) 227 (191–267)
Erythropoietin (mIU/ml) 11.5 (8.8–17.2)** 12.1 (9.7–15.0)** 9.6 (7.5–12.8)
Creatinine (µmol/l) 105 (88–135)** 93 (79–100) 91 (80–106)
MDRD (ml/min/1.73 m2) 48 (37–66)** 62 (54–68) 58 (50–68)
Albumin (g/l) 39 (36–41)** 39 (36–41)** 41 (39–43)
CRP (mg/l) 6.0 (2.0–12.0)** 4.0 (1.0–8.0) 3.0 (0.0–7.0)
Ferritin (mg/l) 103 (37–229)* 93 (49–190) 118 (64–202)
Vitamin B12 (pmol/l) 282 (190–339) 302 (209–451) 256 (204–338)
Folic acid (nmol/l) 11 (9–14)** 13 (11–17) 13 (10–16)
MCV, mean corpuscular volume; CRP, C-reactive protein.
Data are presented in median (inter-quartile range). P-value calculated by the Mann–Whitney U test.
*P < 0.05, **P≤ 0.01 compared with subjects without anaemia.
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36.8% of the anaemic participants [18]. Moreover, in a
study conducted among subjects of a nursing facility almost
one-third of the anaemic subjects qualified as clinically un-
explained [17]. Hence, our findings on the prevalence of
explained and unexplained anaemia in elderly subjects cor-
responds well with the prevalences reported in the
literature.
We found a twofold increased mortality risk in older
persons with explained anaemia compared with the non-
anaemic subjects. We regarded subjects as having explained
anaemia when they met obvious clinical criteria as causes for
anaemia, i.e. iron, folate, vitamin B12 deficiency, renal failure
and MDS. Because of the design of our study, we were not
informed about the specific underlying diseases causing these
types of anaemia. The reason for the observed difference in
mortality between the subjects with explained anaemia and
unexplained anaemia or without anaemia is not obvious
from our study. Between the three groups no differences in
the cause of death were found. It is tempting to speculate
that persons with iron deficiency would have an increased
mortality risk because of the presence of intestinal malig-
nancy and that persons with a renal anaemia would preferably
die because of cardiovascular disease. However, further ana-
lysis of our data failed to demonstrate such relationships,
probably because of the small number of subjects.
Higher serum CRP levels were found in the group of
subjects with explained anaemia when compared with sub-
jects with unexplained anaemia and subjects without
anaemia. It may therefore be suggested that the underlying
cause of the anaemia is associated with a chronic inflamma-
tory response that may contribute to the observed increased
mortality. Since there was significant predominance of renal
insufficiency and myocardial infarction in the explained
group the observed elevated CRP may be the result of the
inflammatory status due to underlying atherosclerotic disease.
In contrast to the group of subjects with known causes
for anaemia, the group with unexplained anaemia had no
increased mortality risk. To our knowledge, this is a new
finding with potentially important clinical implications. It
possibly suggests that when in older persons no cause for
an anaemia can be demonstrated by laboratory measure-
ments, no further clinical investigations might be necessary.
Anaemia in general is associated with an increased mortality
risk, also in the oldest old [4–6]. An explanation for the
present observation is still subject to speculation. It can be
hypothesised that in subjects with unexplained anaemia, a
relatively low haemoglobin level is part of their ‘normal’
phenotype. However, the fact that erythropoietin levels in
the subjects with unexplained anaemia were similar to the
level in the group with explained anaemia, might suggest a
physiological response to a relatively low haemoglobin level
in these subjects. Based on the selection criteria used for
this group, the absence of increased co-morbidity and the
relatively normal CRP levels, it could be suggested that
anaemia in this group might be caused by impaired erythro-
cyte production due to an age-associated diminished haem-
atopoietic stem cell proliferative capacity or, as suggested
earlier, or by an one lineage MDS presenting as anaemia
without white blood cell or platelet features with a very low
risk of further deterioration [15]. However, new studies are
required to shed light on this clinically important finding.
Our study contributes to the extensive discussion about
the relationship between ageing and anaemia. A strong
point of our study is its prospective follow-up setting, per-
mitting us to analyse survival of the oldest old subjects aged
86 years. A limitation of the study is the relatively limited
sample size of subjects with explained and unexplained
anaemia. However, as mentioned, the prevalence of the sub-
jects with unexplained anaemia is remarkably similar to
those reported in other studies [1, 17]. Therefore, we believe
that our findings may have a high external validity. Another
limitation is that we were only able to draw conclusions of
subjects of 86 years or older who were still alive, more re-
search have to be done on the impact of unexplained
anaemia and mortality of subjects younger than 86 years.
In conclusion, the present findings show that in contrast
to older subjects with explained cause for anaemia, older
subjects with unexplained anaemia based on initial laboratory
measurements have no increased mortality risk compared
with subjects without anaemia, suggesting that further clinical
and often invasive evaluation to the cause of anaemia is pos-
sibly not necessary in this very old group of patients. This
observation should be confirmed in other prospective obser-
vational studies and in dedicated intervention studies.
Key points
• Increased mortality risks were found in older subjects
with explained anaemia.
• Older subjects with unexplained anaemia had similar sur-
vival compared with non-anaemic subjects.
• Further clinical invasive evaluation to the cause of
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